BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6802938)

  • 1. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
    Fogelman I; Bessent R
    J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole body retention of diphosphonate in rheumatoid arthritis.
    Steven MM; Sturrock RD; Fogelman I; Smith ML
    J Rheumatol; 1982; 9(6):873-7. PubMed ID: 7161778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retention of 99mTc-diphosphonate in the bones and soft tissues of rats: distribution, time factors, the effect of age].
    Kapitola J; Kobos L; Jahoda I; Vilimovská D
    Sb Lek; 1987; 89(2-3):60-6. PubMed ID: 3589471
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole body retention of 99mTc-diphosphonate. Relation to biochemical indices of bone turnover and to total body calcium.
    Thomsen K; Johansen J; Nilas L; Christiansen C
    Eur J Nucl Med; 1987; 13(1):32-5. PubMed ID: 3109915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
    Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
    Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
    Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
    Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body retention of 99mTc-MPD in Paget's disease.
    Vattimo A; Cantalupi D; Righi G; Martini G; Nuti R; Turchetti V
    J Nucl Med Allied Sci; 1981; 25(1-2):5-10. PubMed ID: 6454766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
    Vattimo A; Martini G
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1614-7. PubMed ID: 6230088
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Coupal JJ
    Calcif Tissue Int; 1981; 33(5):555. PubMed ID: 6797708
    [No Abstract]   [Full Text] [Related]  

  • 11. Skeletal uptake of diphosphonate. Method for prediction of post-menopausal osteoporosis.
    Fogelman I; Bessent RG; Cohen HN; Hart DM; Lindsay R
    Lancet; 1980 Sep; 2(8196):667-70. PubMed ID: 6106785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.
    Hyldstrup L; Mogensen N; Jensen GF; McNair P; Transbøl I
    Scand J Clin Lab Invest; 1984 Apr; 44(2):105-9. PubMed ID: 6426035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of skeletal uptake of 99mTc-diphosphonate over a five day period.
    Fogelman I; Martin W
    Eur J Nucl Med; 1983; 8(11):489-90. PubMed ID: 6653609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accumulation of sodium 2,3-dicarboxypropan-1,1-diphosphonate in bone of rabbits (author's transl)].
    Nagai K; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Muranaka A; Ito Y
    Radioisotopes; 1982 Apr; 31(4):197-8. PubMed ID: 6213983
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.
    Fogelman I; Bessent RG; Beastall G; Boyle IT
    Ann Intern Med; 1980 Jan; 92(1):65-7. PubMed ID: 6766051
    [No Abstract]   [Full Text] [Related]  

  • 17. Does radiolabelled diphosphonate retention reflect bone metabolism in the elderly?
    Webb AJ; Sinha B; Briggs RS; Fleming J; Ackery D
    Age Ageing; 1986 May; 15(3):164-8. PubMed ID: 3739853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of age on the 24-hour retention of TC-99m methylene diphosphonate in rats].
    Kapitola J; Kobos L; Jahoda I
    Sb Lek; 1987 Apr; 89(4):102-7. PubMed ID: 3112927
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased bone metabolism in rheumatoid arthritis as measured by the whole-body retention of 99Tcm methylene diphosphonate.
    Rajapakse C; Thompson R; Grennan DM; Winston BM; Patel P; Nuttall PM; Murphy J; Weiss JB
    Ann Rheum Dis; 1983 Apr; 42(2):138-41. PubMed ID: 6221703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m phytate as a bone-marrow imaging agent: biodistribution studies in animals: concise communication.
    Hamilton RG; Alderson PO; Mclntyre PA
    J Nucl Med; 1977 Jun; 18(6):563-5. PubMed ID: 859038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.